Item 1.01 Entry into a Material Definitive
Agreement.
On May 16, 2023, Inpixon (the
“Company”) entered into an amendment (the “July 2022 Note Amendment”) to that certain Promissory Note, dated July
22, 2022, as amended on January 31, 2023 (as amended, the “July 2022 Note”), issued to Streeterville Capital, LLC (“Streeterville”)
in the initial principal amount of $6,465,000. Pursuant to the terms of the July 2022 Note Amendment, the maturity date of the July 2022
Note was extended from July 22, 2023 to May 17, 2024 (the “July 2022 Note Maturity Date Extension”). In exchange for the July
2022 Note Maturity Date Extension, the Company agreed to pay Streeterville an extension fee in the amount of $56,568.99 (the “July
2022 Note Extension Fee”), which was added to the outstanding balance of the July 2022 Note. Following the application of the July
2022 Note Extension Fee, as of May 16, 2023, the outstanding balance of the July 2022 Note was $5,715,039.39.
Additionally, on May 16, 2023,
the Company entered into an amendment (the “December 2022 Note Amendment”) to that certain
Promissory Note, dated December 30, 2022 (the “December 2022 Note”), issued
to Streeterville in the initial principal amount of $8,400,000. Pursuant to the terms of
the December 2022 Note Amendment, the maturity date of the December 2022 Note was extended from December 30, 2023 to May 17, 2024 (the
“December 2022 Note Maturity Date Extension”). In exchange for the December 2022 Note Maturity Date Extension, the Company
agreed to pay Streeterville an extension fee in the amount of $87,233.58 (the “December 2022 Note Extension Fee”), which was
added to the outstanding balance of the December 2022 Note. Following the application of the December 2022 Note Extension Fee, as of May
16, 2023, the outstanding balance of the December 2022 Note was $8,813,014.58.
Streeterville also holds 75,000,000
warrants to purchase 75,000,000 shares of the Company’s common stock, par value $0.001 per share, issued on May 17, 2023.
The foregoing description
of the July 2022 Note Amendment and the December 2022 Note Amendment does not purport to be complete and is qualified in its entirety
by reference to the full text of the July 2022 Note Amendment and the December 2022 Note Amendment, copies of which are filed as Exhibits
10.1 and 10.2, respectively, to this Current Report on Form 8-K, and are incorporated herein by reference. The terms of the July 2022
Note were previously disclosed in Item 1.01 of the Company’s Current Report on Form 8-K filed with the U.S. Securities and Exchange
Commission (the “SEC”) on July 22, 2022, which description is incorporated herein by reference. The terms of the December
2022 Note were previously disclosed in Item 1.01 of the Company’s Current Report on Form 8-K filed with the SEC on December 30,
2022, which description is incorporated herein by reference.